Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000035401 | SCV000059049 | likely benign | not specified | 2015-03-27 | criteria provided, single submitter | clinical testing | p.Asp489Asp in exon 17 of MYBPC3: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 0.3% (29/8624) o f East Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac. broadinstitute.org; dbSNP rs35690719). |
Invitae | RCV000232444 | SCV000284210 | benign | Hypertrophic cardiomyopathy | 2024-01-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001311764 | SCV000729091 | likely benign | not provided | 2020-12-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000611831 | SCV000744851 | benign | Hypertrophic cardiomyopathy 4 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001186655 | SCV001353187 | benign | Cardiomyopathy | 2018-08-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390141 | SCV002697477 | likely benign | Cardiovascular phenotype | 2018-04-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004549412 | SCV004719140 | likely benign | MYBPC3-related disorder | 2019-07-30 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
All of Us Research Program, |
RCV000232444 | SCV004834621 | benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000611831 | SCV000733050 | likely benign | Hypertrophic cardiomyopathy 4 | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001311764 | SCV001927625 | likely benign | not provided | no assertion criteria provided | clinical testing |